{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:09:40Z","timestamp":1748995780626},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,3,15]],"date-time":"2003-03-15T00:00:00Z","timestamp":1047686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s00228-003-0563-9","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T18:46:56Z","timestamp":1478976416000},"page":"829-833","source":"Crossref","is-referenced-by-count":15,"title":["Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles"],"prefix":"10.1007","volume":"58","author":[{"given":"Yutaro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Shioiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyuki","family":"Muratake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieko","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,15]]},"reference":[{"key":"0563_CR1","unstructured":"Greenblatt DJ, von Moltke LL, Harmatz JS, Shader (1998) Drug interactions with newer antidepressants: role of human cytochromes P450. J Clin Psychiatry 59[Suppl 15]:19\u201327"},{"key":"0563_CR2","doi-asserted-by":"crossref","unstructured":"Jefferson JW (1998) Drug interactions\u2014friend or foe? J Clin Psychiatry 59[Suppl 4]:37\u201347","DOI":"10.4088\/JCP.v59n0207i"},{"key":"0563_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2125.1994.tb04317.x","volume":"38","author":"von","year":"1994","unstructured":"von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI (1994) Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 38:23\u201331","journal-title":"Br J Clin Pharmacol"},{"key":"0563_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s002130050715","volume":"139","author":"Yasui","year":"1998","unstructured":"Yasui N, Kondo T, Otani K, Furukori H, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K (1998) Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology 139:269\u2013273","journal-title":"Psychopharmacology"},{"key":"0563_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0893-133X(97)00166-8","volume":"18","author":"Furukori","year":"1998","unstructured":"Furukori H, Otani K, Yasui N, Kondo T, Kaneko S, Shimoyama R, Ohkubo T, Nagasaki T, Sugawara K (1998) Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam. Neuropsychopharmacology 18:364\u2013369","journal-title":"Neuropsychopharmacology"},{"key":"0563_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004714-199504000-00008","volume":"15","author":"von","year":"1995","unstructured":"von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI (1995) Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. J Clin Psychopharmacol 15:125\u2013131","journal-title":"J Clin Psychopharmacol"},{"key":"0563_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00195913","volume":"46","author":"Fleishaker","year":"1994","unstructured":"Fleishaker JC, Hulst LK (1994) A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine. Eur J Clin Pharmacol 46:35\u201339","journal-title":"Eur J Clin Pharmacol"},{"key":"0563_CR8","unstructured":"Ruiz P (2000) Ethnicity and psychopharmacology. Review of psychiatry series, vol. 19, no. 4. American Psychiatric Press, Washington"},{"key":"0563_CR9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","volume":"10","author":"Hoddes","year":"1973","unstructured":"Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973) Quantification of sleepiness: a new approach. Psychophysiology 10:431\u2013436","journal-title":"Psychophysiology"},{"key":"0563_CR10","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","volume":"269","author":"de","year":"1994","unstructured":"de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA (1994) The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 269:15419\u201315422","journal-title":"J Biol Chem"},{"key":"0563_CR11","first-page":"139","volume":"2","author":"Smith","year":"1983","unstructured":"Smith RB, Gwilt PR, Wright CE III (1983) Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men. Clin Pharm 2:139\u2013143","journal-title":"Clin Pharm"},{"key":"0563_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0893-133X(96)00165-0","volume":"16","author":"Otani","year":"1997","unstructured":"Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Hayashi K, Chiba K, Ishizaki T (1997) Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam. Neuropsychopharmacology 16:8\u201314","journal-title":"Neuropsychopharmacology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-003-0563-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0563-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:06:24Z","timestamp":1692569184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-003-0563-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,15]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["0563"],"URL":"https:\/\/doi.org\/10.1007\/s00228-003-0563-9","relation":{},"ISSN":["0031-6970"],"issn-type":[{"value":"0031-6970","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,15]]}}}